A prospective 2-year study of emergency department patients with early-phase primary psychosis or substance-induced psychosis

American Journal of Psychiatry

Volumn 168, Issue 7, 2011, Pages 742-748

  Drake, Robert E ^a,b,c   Caton, Carol L M ^a,b,c   Xie, Haiyi ^a,b,c   Hsu, Eustace ^a,b,c   Gorroochurn, Prakash ^a,b,c   Samet, Sharon ^a,b,c   Hasin, Deborah S ^a,b,c  

^a DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

^b Columbia University ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; DIAMORPHINE; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE COURSE; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MOOD DISORDER; PATIENT SATISFACTION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE; SUBSTANCE INDUCED PSYCHOSIS; SYMPTOMATOLOGY; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AMBULATORY CARE; COHORT STUDIES; COMORBIDITY; CRISIS INTERVENTION; DIAGNOSIS, DUAL (PSYCHIATRY); EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEW YORK CITY; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 79956363534     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.10071051     Document Type: Article

References (32)

1. Kêdoté M, Brousselle A, Champagne F: Use of health services by patients with co-occurring severe mental illness and substance use disorders. Ment Health Subst Use 2008; 1:216-227
2. McGorry PD, Killackey E, Yung A: Early intervention in psychosis: concepts, evidence, and future directions. World Psychiatry 2008; 7:148-156
3. Freudenreich O, Holt DJ, Cather C , Goff DC: The evaluation and management of patients with first-episode schizophrenia: a selective clinical review of diagnosis, treatment, and prognosis. Harv Rev Psychiatry 2007; 15:189-211 (Pubitemid 47557206)
4. Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L, Ji Z, Koch G, Hamer RM: Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology 2003; 28:995-1003
5. Tohen M, Strakowski SM, Zarate C , Hennen J, Stoll AL, Suppes T, Faedda G, Cohen BM, Gebre-Medhin P, Baldessarini RJ: The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry 2000; 48:467-476
6. Addington J, Addington D: Effect of substance misuse in early psychosis. Br J Psychiatry Suppl 1998; 172:134-136 (Pubitemid 28258912)
7. Perkins DO, Johnson JL, Hamer RM, Zipursky RB, Keefe RS, Centorrhino F, Green AI, Glick IB, Kahn RS, Sharma T, Tohen M, McEvoy JP, Weiden PJ, Lieberman JA; HGDH Research Group: Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res 2006; 83:53-63
8. Mathias S, Lubman DI, Hides L: Substance-induced psychosis: a diagnostic conundrum. J Clin Psychiatry 2008; 69:358-367 (Pubitemid 351549387)
9. Li HL: An archaeological and historical account of cannabis in China. Economic Botany 1974; 28:437-448
10. Basu D, Malhotra A, Bhagat A, Varma VK: Cannabis psychosis and acute schizophrenia: a case-control study from India. Eur Addiction Res 1999; 5:71-73 (Pubitemid 29312950)
11. Ellinwood EH Jr: Amphetamine psychosis, I: description of the individuals and process. J Nerv Ment Dis 1967; 144:273-283
12. McLellan TA, Woody GE, O'Brien CP: Development of psychiatric illness in drug abusers. N Engl J Med 1979; 301:1310-1314
13. Harris D, Batki SL: Stimulant psychosis: symptoms profile and acute clinical course. Am J Addict 2000; 9:28-37 (Pubitemid 30155031)
14. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). Washington, DC, American Psychiatric Association, 1994
15. Henquet C , Krabbendam L, Spauwen J, Kaplan C , Lieb R, Wittchen HU, van Os J: Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330:11-14 (Pubitemid 40070467)
16. Brady KT, Sonne S, Randall CL, Adinoff B, Malcolm R: Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend 1995; 39:69-71
17. Dawson R, Green AI, Drake RE, Lavori PW, McGlashan TH, Schanzer B: An adaptive strategy paradigm for longitudinal treatment research using substance-induced psychosis as an example. Psychopharmacol Bull 2008; 41:51-67
18. Caton C , Drake RE, Hasin DS, Dominguez B, Shrout P, Samet S, Schanzer WB: Differences between early-phase primary psychotic disorders with concurrent substance use and substanceinduced psychoses. Arch Gen Psychiatry 2005; 62:137-145 (Pubitemid 40189129)
19. Caton C , Hasin DS, Shrout PE, Drake RE, Dominguez B, First MB, Samet S, Schanzer B: Stability of DSM-IV diagnoses of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis on one-year follow-up. Br J Psychiatry 2007; 190:105-111
20. Bromet EJ, Schwartz JE, Fennig S, Geller L, Jandorf L, Kovasznay B, Lavelle J, Miller A, Pato C , Ram R: The epidemiology of psychosis: the Suffolk County Mental Health Project. Schizophr Bull 1992; 18:243-255
21. Caton CLM: The Community Care Schedule, Modified Version. New York, New York State Psychiatric Institute, 1997
22. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R: Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry 2006; 163:689-696 (Pubitemid 44464580)
23. Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J: Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry 1996; 153:1195-1201 (Pubitemid 26299841)
24. Kay SR, Opler LA, Fiszbein A: The Positive and Negative Syndrome Scale Manual. Toronto, Multi-Health Systems, 1992
25. World Health Organization: Psychiatric Disability Assessment Schedule (WHO/DAS) With a Guide to Its Use. Geneva, World Health Organization, 1988
26. Lehman AF: A Quality of Life Interview for the chronically mentally ill. Evaluation and Program Planning 1988; 11:51-62
27. Hasin D, Hatzenbuehler ML, Keyes K, Ogburn E: Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth ed (DSM-IV), and International Classification of Diseases, tenth ed (ICD-10). Addiction 2006; 101:59-75 (Pubitemid 44199497)
28. Diggle PJ, Heagerty P, Liang KY, Ziegler SL: Analysis of Longitudinal Data, 2nd ed. Oxford, England, Oxford University Press, 2002
29. SAS Institute: SAS/STAT User's Guide, Version 9.2. Cary, NC, SAS Institute, 2008
30. Archie S, Rush BR, Akhtar-Danesh N, Norman R, Malla A, Roy P, Zipursky RB: Substance use and abuse in first-episode psychosis: prevalence before and after early intervention. Schizophr Bull 2007; 33:1354-1363 (Pubitemid 350022769)
31. McCleery A, Addington J, Addington D: Substance misuse and cognitive functioning in early psychosis: a 2-year follow-up. Schizophr Res 2006; 88:187-191 (Pubitemid 44693239)
32. Mojtabai R, Fochtmann L, Chang SW, Kotov R, Craig TJ, Bromet E: Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study. Schizophr Bull 2009; 35:679-695